Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001096906-25-001711
Filing Date
2025-10-24
Accepted
2025-10-24 13:40:30
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 8382
  Complete submission text file 0001096906-25-001711.txt   11134
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Issuer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
EVANS BARRETT (Reporting) CIK: 0001277242 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12555 | Film No.: 251415526

Mailing Address 1712 PIONEER AVE SUITE 558 CHEYENNE WY 82001
Business Address 1712 PIONEER AVE SUITE 558 CHEYENNE WY 82001 562-221-0341
Mammoth Crest Capital LLC (Reporting) CIK: 0001877347 (see all company filings)

State of Incorp.: WY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-12555 | Film No.: 251415524

Mailing Address 201 W MONTECITO STREET SANTA BARBARA CA 93101
Business Address 201 W MONTECITO STREET SANTA BARBARA CA 93101 562-221-0341
EMC2 Capital LLC (Reporting) CIK: 0001905629 (see all company filings)

State of Incorp.: WY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-12555 | Film No.: 251415525